213 related articles for article (PubMed ID: 12892857)
1. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.
Jeste SD; Patterson TL; Palmer BW; Dolder CR; Goldman S; Jeste DV
Schizophr Res; 2003 Sep; 63(1-2):49-58. PubMed ID: 12892857
[TBL] [Abstract][Full Text] [Related]
2. Assessment of medication management ability in middle-aged and older adults with bipolar disorder.
Depp CA; Cain AE; Palmer BW; Moore DJ; Eyler LT; Lebowitz BD; Patterson TL; Jeste DV
J Clin Psychopharmacol; 2008 Apr; 28(2):225-9. PubMed ID: 18344736
[TBL] [Abstract][Full Text] [Related]
3. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
[TBL] [Abstract][Full Text] [Related]
4. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
[TBL] [Abstract][Full Text] [Related]
5. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
6. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia.
El-Missiry A; Elbatrawy A; El Missiry M; Moneim DA; Ali R; Essawy H
J Psychiatr Res; 2015 Nov; 70():106-12. PubMed ID: 26424429
[TBL] [Abstract][Full Text] [Related]
7. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
Nakonezny PA; Byerly MJ; Rush AJ
Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
[TBL] [Abstract][Full Text] [Related]
8. Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients.
Evans JD; Negron AE; Palmer BW; Paulsen JS; Heaton RK; Jeste DV
J Geriatr Psychiatry Neurol; 1999; 12(1):11-5. PubMed ID: 10447149
[TBL] [Abstract][Full Text] [Related]
9. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
[TBL] [Abstract][Full Text] [Related]
10. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
[TBL] [Abstract][Full Text] [Related]
11. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
12. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
13. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
Minzenberg MJ; Poole JH; Benton C; Vinogradov S
Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
[TBL] [Abstract][Full Text] [Related]
14. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia.
Twamley EW; Woods SP; Zurhellen CH; Vertinski M; Narvaez JM; Mausbach BT; Patterson TL; Jeste DV
Schizophr Res; 2008 Nov; 106(1):42-9. PubMed ID: 18055178
[TBL] [Abstract][Full Text] [Related]
16. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.
Donohoe G; Owens N; O'Donnell C; Burke T; Moore L; Tobin A; O'Callaghan E
Eur Psychiatry; 2001 Aug; 16(5):293-8. PubMed ID: 11514132
[TBL] [Abstract][Full Text] [Related]
17. Understanding adherence to neuroleptic treatment in schizophreniaí.
Vauth R; Löschmann C; Rüsch N; Corrigan PW
Psychiatry Res; 2004 Apr; 126(1):43-9. PubMed ID: 15081626
[TBL] [Abstract][Full Text] [Related]
18. Predictors of medication competence in schizophrenia patients.
Heinrichs RW; Goldberg JO; Miles AA; McDermid Vaz S
Psychiatry Res; 2008 Jan; 157(1-3):47-52. PubMed ID: 17897721
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
[TBL] [Abstract][Full Text] [Related]
20. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
